Imperagen: SeedUses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial marketsOct 4, 2026RoundOSImperagenCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeed · AIBiotechUnited KingdomSeed · United KingdomEuropeSeed